Demands and requests for ‘inappropriate’ or ‘inadvisable’ treatments at the end of life: what do you do at 2 o’clock in the morning when …? von McCrossan, L., Siegmeth, R.

Volltext

A fatal case of amphetamine induced ischaemic colitis von Green, P A, Battersby, Clf, Heath, R M, McCrossan, L

Volltext

Assessing fluid responsiveness by stroke volume variation in mechanically ventilated patients with severe sepsis von Marx, G., Cope, T., McCrossan, L., Swaraj, S., Cowan, C., Mostafa, S. M., Wenstone, R., Leuwer, M.

Volltext

Blood transfusion in critical illness von McCrossan, L, Masterson, G

Volltext

How is sedation provided for percutaneous dilatational tracheostomy in English ICUs? von Hampshire, P, McCrossan, L

Volltext

Editorial III: Blood transfusion in critical illness von McCrossan, L., Masterson, G.

Volltext

Outcome of faecal peritonitis in the ICU von Sayer, J, Simpson, G, Mccrossan, L, Welters, I

Volltext

Assessing fluid responsiveness by stroke volume variation in mechanically ventilated patients with severe sepsis von Marx, G., Cope, T., McCrossan, L., Swaraj, S., Cowan, C., Mostafa, S. M., Wenstone, R., Leuwer, M.

Volltext

Editorial III von McCrossan, L., Masterson, G.

Volltext

Can we distinguish patients at risk of deterioration? von McCrossan, L, Peyrasse, P, Vincent, L, Burgess, L, Harper, S

Volltext

P084 Are cystic fibrosis teams using sweat chloride as a clinical biomarker when prescribing CFTR modulators? von McCrossan, P., Thomson, L.

Volltext

A national survey of out‐of‐hours working and fatigue in consultants in anaesthesia and paediatric intensive care in the UK and Ireland von McClelland, L., Plunkett, E., McCrossan, R., Ferguson, K., Fraser, J., Gildersleve, C., Holland, J., Lomas, J. P., Redfern, N., Pandit, J. J.

Volltext

P220 Increased incidence of Mycoplasma pneumoniae in a Regional Paediatric Cystic Fibrosis Centre von Jenkins, L., McCrossan, P., Galway, N., Keown, K., McCaughan, J., Moore, J.

Volltext

WS12.03 Elexacaftor/tezacaftor/ivacaftor (ETI) therapy increases fat-soluble vitamin levels in children with cystic fibrosis von Sahibqran, M., Crocker, J., Langley, R., Devenny, A., McCrossan, P., Thomson, L.

Volltext

P195 Vaping and cystic fibrosis: current perceptions and future directions von Langley, R., Sahibqran, M., MacGregor, G., Thomson, L., McCrossan, P., Devenny, A.

Volltext

Let’s Get Walking: Establishing Workplace Walking Groups in a regional Public Health Department von Kelly, C, O’Kane, G, Edwards, D, Lee, J, McCrossan, D, Smith, L, Farmer, W, Conlan, C, Fallon, U, Cooney, F

Volltext

Mentoring for doctors in the UK: what it can do for you, your colleagues, and your patients von McCrossan, R., Swan, L., Redfern, N.

Volltext

P620 Can ustekinumab trough and antidrug antibody levels post induction predict treatment failure? von Mccrossan, M, O’Moráin, N, Kumar, L, Rowan, C, Sheridan, J, Cullen, G, Doherty, G, Mulcahy, H

Volltext

Tu1282 – Clinical Characteristics and Treatment Response of Esophagogastric Junction Outflow Obstruction von Elsbernd, Benjamin L., McCrossan, Geoffrey, Dunbar, Kerry B., Jeon-Slaughter, Haekyung, Nguyen, Anh D.

Volltext

Eliminating Indigenous Jurisdictions: Federalism, the Supreme Court of Canada, and Territorial Rationalities of Power von McCrossan, Michael, Ladner, Kiera L.

Volltext